Clear Path For AstraZeneca’s Roxadustat After Reassuring Safety Data

Filing Expected Before Year-End

 
• By Andrew McConaghie
  
AZ_China
AstraZeneca's operations in China, where roxodustat is already approved • Source: AstraZeneca
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D